As of Oct 21
| -0.77 / -0.87%|
The 17 analysts offering 12-month price forecasts for Incyte Corp have a median target of 100.00, with a high estimate of 121.00 and a low estimate of 87.00. The median estimate represents a +14.00% increase from the last price of 87.72.
The current consensus among 19 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.